Evidence map›Paper›PMID 37366520›Full record

ArticleHeliyon2023

Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine.

Michelle C Archer, Joseph McCollum, Christopher Press, Timothy S Dutill, Hong Liang, Dawn Fedor, Liam Kapilow-Cohen, Alana Gerhardt, Tony Phan, Edward H Trappler and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michelle C ArcherInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Joseph McCollumAccess to Advanced Health Institute (AAHI), Formerly IDRI, Seattle, WA, USA.
Christopher PressAccess to Advanced Health Institute (AAHI), Formerly IDRI, Seattle, WA, USA.
Timothy S DutillLyophilization Technology, Inc. (LTI), Warminster, PA, USA.
Hong LiangInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Dawn FedorInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Liam Kapilow-CohenInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Alana GerhardtAccess to Advanced Health Institute (AAHI), Formerly IDRI, Seattle, WA, USA.
Tony PhanInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Edward H TrapplerLyophilization Technology, Inc. (LTI), Warminster, PA, USA.
Mark T OrrInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Ryan M KramerInfectious Disease Research Institute (IDRI), Seattle, WA, USA.
Christopher B FoxAccess to Advanced Health Institute (AAHI), Formerly IDRI, Seattle, WA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the recent exception of coronavirus disease 2019 (COVID-19), tuberculosis (TB) causes more deaths globally than any other infectious disease, and approximately 1/3 of the world's population is infected with

Indexed as

Cold chainGLA-SEID93LyophilizationThermostabilityVaccine formulation

Identifiers

PMID37366520
PMCPMC10278894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.